BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial

OBJECTIVE: This study evaluated the performance of the novel liquid fiducial marker (BioXmark®) in IGRT for bladder cancer. METHODS: 20 patients with muscle invasive bladder cancer were entered in this prospective, single center, Phase I-II study. The novel BioXmark(®) liquid markers were injected a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Br J Radiol
Autores principales: de Ridder, Mischa, Gerbrandy, Lara C, de Reijke, Theo M, Hinnen, Karel A, Hulshof, Maarten C.C.M.
Formato: Artigo
Lenguaje:Inglês
Publicado: The British Institute of Radiology. 2020
Materias:
Full Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336065/
https://ncbi.nlm.nih.gov/pubmed/32463291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1259/bjr.20200241
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares